Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Mar;117(5):931–937. doi: 10.1111/j.1476-5381.1996.tb15283.x

Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex.

T P Obrenovitch 1, E Zilkha 1
PMCID: PMC1909404  PMID: 8851513

Abstract

1. Spreading depression (SD) is a propagating transient suppression of electrical activity, associated with cellular depolarization, which probably underlies the migraine aura and may contribute to neuronal damage in focal ischaemia. The purpose of this study was to examine whether L-701,324 (7-chloro-4-hydroxy-3-(3-phenoxy)phenyl-2-(1H)-quinolone), a high affinity antagonist at the glycine site of the N-methyl-D-aspartate (NMDA) receptor complex, inhibits the initiation and propagation of K(+)-induced SD in the rat cerebral cortex in vivo. 2. Microdialysis probes incorporating a recording electrode were implanted in the cerebral cortex of anaesthetized rats and perfused with artificial cerebrospinal fluid (ACSF). Five episodes of repetitive SD were elicited by switching to a medium containing 130 mM K+ for 20 min, each separated by 40 min of recovery (i.e. perfusion with normal ACSF). The brief negative shifts of the extracellular direct current (d.c.) potential, characteristic of SD elicitation, were recorded with the microdialysis electrode and a reference electrode placed under the scalp. Propagation of SD was examined using glass capillary electrodes inserted about 3 mm posterior to the microdialysis electrode. L-701,324 (5 or 10 mg kg-1) or its vehicle were administered i.v. 10 min after the end of the second K(+)-stimulus. The effects of L-701,324 were compared to those of dizocilpine (MK-801; 1 mg kg-1 i.v.), a NMDA-channel blocker known to potently block SD elicitation. 3. Potassium-induced SD initiation was inhibited by 10 mg kg-1 (but not by 5 mg kg-1) of L-701,324. Thirty minutes after administration of 10 mg kg-1 L-701,324, the cumulative area of SD peaks elicited during 20 min was 15.3 +/- 2.1 mV min, versus 23.2 +/- 1.1 mV min in animals which received only the drug vehicle (P < 0.02; n = 6). The delay between application of 130 mM K+ and occurrence of the first SD was also significantly increased. It was approximately doubled in animals treated with 10 mg kg-1 of L-701,324. 4. SD propagation was more sensitive than SD elicitation to L-701,324, as both 5 and 10 mg kg-1 produced an effective inhibition. Even at the lower dose of 5 mg kg-1, L-701,324 completely blocked the propagation of SD elicited 30 min after drug administration. This differential sensitivity of SD elicitation and propagation is not specific to L-701,324 since it was previously observed with other drugs. At doses effective against SD, L-701,324 did not produce any marked alterations of the electroencephalogram. 5. L-701,324 (10 mg kg-1) and MK-801 (1 mg kg-1) had identical effects on the d.c. potential when administered during the recovery which followed the second K+ stimulus. Both drugs produced a positive shift of around 4.5 mV within 10 min of i.v. drug administration, indicating rapid drug penetration into the CNS. Paradoxically, L-701,324 (10 mg kg-1) was markedly less effective than MK-801 (1 mg kg-1) in blocking SD, since this dose of MK-801 was sufficient virtually to abolish SD initiation and completely block its propagation. The higher potency of MK-801 against SD may reflect its use-dependency, i.e. binding of MK-801 and channel blockade are enhanced when the NMDA-receptor ionophore is open. 6. Taken together, these data demonstrate that L-701,324 has an inhibitory effect on both SD initiation and propagation. This action may be beneficial in focal ischaemia, and possibly also against migraine, especially as this drug was shown to be active when administered orally.

Full text

PDF
931

Images in this article

934Figure 4
on p.934
935Figure 6
on p.935

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carlà V., Moroni F. General anaesthetics inhibit the responses induced by glutamate receptor agonists in the mouse cortex. Neurosci Lett. 1992 Oct 26;146(1):21–24. doi: 10.1016/0304-3940(92)90162-z. [DOI] [PubMed] [Google Scholar]
  2. Carter A. J. Many agents that antagonize the NMDA receptor-channel complex in vivo also cause disturbances of motor coordination. J Pharmacol Exp Ther. 1994 May;269(2):573–580. [PubMed] [Google Scholar]
  3. Croucher M. J., Collins J. F., Meldrum B. S. Anticonvulsant action of excitatory amino acid antagonists. Science. 1982 May 21;216(4548):899–901. doi: 10.1126/science.7079744. [DOI] [PubMed] [Google Scholar]
  4. Duckrow R. B. Regional cerebral blood flow during spreading cortical depression in conscious rats. J Cereb Blood Flow Metab. 1991 Jan;11(1):150–154. doi: 10.1038/jcbfm.1991.18. [DOI] [PubMed] [Google Scholar]
  5. Foster A. C., Wong E. H. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Br J Pharmacol. 1987 Jun;91(2):403–409. doi: 10.1111/j.1476-5381.1987.tb10295.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gardner-Medwin A. R. Possible roles of vertebrate neuroglia in potassium dynamics, spreading depression and migraine. J Exp Biol. 1981 Dec;95:111–127. doi: 10.1242/jeb.95.1.111. [DOI] [PubMed] [Google Scholar]
  7. Hargreaves R. J., Rigby M., Smith D., Hill R. G. Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology. Br J Pharmacol. 1993 Sep;110(1):36–42. doi: 10.1111/j.1476-5381.1993.tb13768.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hernándéz-Cáceres J., Macias-González R., Brozek G., Bures J. Systemic ketamine blocks cortical spreading depression but does not delay the onset of terminal anoxic depolarization in rats. Brain Res. 1987 Dec 29;437(2):360–364. doi: 10.1016/0006-8993(87)91652-0. [DOI] [PubMed] [Google Scholar]
  9. Herreras O., Somjen G. G. Analysis of potential shifts associated with recurrent spreading depression and prolonged unstable spreading depression induced by microdialysis of elevated K+ in hippocampus of anesthetized rats. Brain Res. 1993 May 7;610(2):283–294. doi: 10.1016/0006-8993(93)91412-l. [DOI] [PubMed] [Google Scholar]
  10. Huettner J. E., Bean B. P. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1307–1311. doi: 10.1073/pnas.85.4.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Iijima T., Mies G., Hossmann K. A. Repeated negative DC deflections in rat cortex following middle cerebral artery occlusion are abolished by MK-801: effect on volume of ischemic injury. J Cereb Blood Flow Metab. 1992 Sep;12(5):727–733. doi: 10.1038/jcbfm.1992.103. [DOI] [PubMed] [Google Scholar]
  12. Koek W., Colpaert F. C. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects. J Pharmacol Exp Ther. 1990 Jan;252(1):349–357. [PubMed] [Google Scholar]
  13. Kulagowski J. J., Baker R., Curtis N. R., Leeson P. D., Mawer I. M., Moseley A. M., Ridgill M. P., Rowley M., Stansfield I., Foster A. C. 3'-(Arylmethyl)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: orally active antagonists of the glycine site on the NMDA receptor. J Med Chem. 1994 May 13;37(10):1402–1405. doi: 10.1021/jm00036a002. [DOI] [PubMed] [Google Scholar]
  14. Lauritzen M., Hansen A. J. The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J Cereb Blood Flow Metab. 1992 Mar;12(2):223–229. doi: 10.1038/jcbfm.1992.32. [DOI] [PubMed] [Google Scholar]
  15. Lauritzen M. Long-lasting reduction of cortical blood flow of the brain after spreading depression with preserved autoregulation and impaired CO2 response. J Cereb Blood Flow Metab. 1984 Dec;4(4):546–554. doi: 10.1038/jcbfm.1984.79. [DOI] [PubMed] [Google Scholar]
  16. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 1994 Feb;117(Pt 1):199–210. doi: 10.1093/brain/117.1.199. [DOI] [PubMed] [Google Scholar]
  17. Leeson P. D., Iversen L. L. The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. J Med Chem. 1994 Nov 25;37(24):4053–4067. doi: 10.1021/jm00050a001. [DOI] [PubMed] [Google Scholar]
  18. Marrannes R., Willems R., De Prins E., Wauquier A. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res. 1988 Aug 9;457(2):226–240. doi: 10.1016/0006-8993(88)90690-7. [DOI] [PubMed] [Google Scholar]
  19. Martin D. C., Abraham J. E., Plagenhoef M., Aronstam R. S. Volatile anesthetics and NMDA receptors. Enflurane inhibition of glutamate-stimulated [3H]MK-801 binding and reversal by glycine. Neurosci Lett. 1991 Oct 28;132(1):73–76. doi: 10.1016/0304-3940(91)90436-w. [DOI] [PubMed] [Google Scholar]
  20. Martin D. C., Plagenhoef M., Abraham J., Dennison R. L., Aronstam R. S. Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors. Biochem Pharmacol. 1995 Mar 15;49(6):809–817. doi: 10.1016/0006-2952(94)00519-r. [DOI] [PubMed] [Google Scholar]
  21. Martin H., Warner D. S., Todd M. M. Effects of glycine receptor antagonism on spreading depression in the rat. Neurosci Lett. 1994 Oct 24;180(2):285–289. doi: 10.1016/0304-3940(94)90540-1. [DOI] [PubMed] [Google Scholar]
  22. Matsumoto K., Graf R., Rosner G., Taguchi J., Heiss W. D. Elevation of neuroactive substances in the cortex of cats during prolonged focal ischemia. J Cereb Blood Flow Metab. 1993 Jul;13(4):586–594. doi: 10.1038/jcbfm.1993.76. [DOI] [PubMed] [Google Scholar]
  23. McFarlane C., Warner D. S., Nader A., Dexter F. Glycine receptor antagonism. Effects of ACEA-1021 on the minimum alveolar concentration for halothane in the rat. Anesthesiology. 1995 Apr;82(4):963–968. doi: 10.1097/00000542-199504000-00020. [DOI] [PubMed] [Google Scholar]
  24. Mutch W. A., Hansen A. J. Extracellular pH changes during spreading depression and cerebral ischemia: mechanisms of brain pH regulation. J Cereb Blood Flow Metab. 1984 Mar;4(1):17–27. doi: 10.1038/jcbfm.1984.3. [DOI] [PubMed] [Google Scholar]
  25. Obrenovitch T. P., Richards D. A., Sarna G. S., Symon L. Combined intracerebral microdialysis and electrophysiological recording: methodology and applications. J Neurosci Methods. 1993 Apr;47(1-2):139–145. doi: 10.1016/0165-0270(93)90030-u. [DOI] [PubMed] [Google Scholar]
  26. Obrenovitch T. P., Urenjak J., Zilkha E. Intracerebral microdialysis combined with recording of extracellular field potential: a novel method for investigation of depolarizing drugs in vivo. Br J Pharmacol. 1994 Dec;113(4):1295–1302. doi: 10.1111/j.1476-5381.1994.tb17139.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Obrenovitch T. P., Zilkha E. High extracellular potassium, and not extracellular glutamate, is required for the propagation of spreading depression. J Neurophysiol. 1995 May;73(5):2107–2114. doi: 10.1152/jn.1995.73.5.2107. [DOI] [PubMed] [Google Scholar]
  28. Obrenovitch T. P., Zilkha E., Urenjak J. Intracerebral microdialysis: electrophysiological evidence of a critical pitfall. J Neurochem. 1995 Apr;64(4):1884–1887. doi: 10.1046/j.1471-4159.1995.64041884.x. [DOI] [PubMed] [Google Scholar]
  29. Puil E., el-Beheiry H. Anaesthetic suppression of transmitter actions in neocortex. Br J Pharmacol. 1990 Sep;101(1):61–66. doi: 10.1111/j.1476-5381.1990.tb12089.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Reid K. H., Marrannes R., Wauquier A. Spreading depression and central nervous system pharmacology. J Pharmacol Methods. 1988 Mar;19(1):1–21. doi: 10.1016/0160-5402(88)90040-x. [DOI] [PubMed] [Google Scholar]
  31. Sheardown M. J. The triggering of spreading depression in the chicken retina: a pharmacological study. Brain Res. 1993 Apr 2;607(1-2):189–194. doi: 10.1016/0006-8993(93)91506-n. [DOI] [PubMed] [Google Scholar]
  32. Szerb J. C. Glutamate release and spreading depression in the fascia dentata in response to microdialysis with high K+: role of glia. Brain Res. 1991 Mar 1;542(2):259–265. doi: 10.1016/0006-8993(91)91576-m. [DOI] [PubMed] [Google Scholar]
  33. Taylor D. L., Richards D. A., Obrenovitch T. P., Symon L. Time course of changes in extracellular lactate evoked by transient K(+)-induced depolarisation in the rat striatum. J Neurochem. 1994 Jun;62(6):2368–2374. doi: 10.1046/j.1471-4159.1994.62062368.x. [DOI] [PubMed] [Google Scholar]
  34. Verhaegen M., Todd M. M., Warner D. S. The influence of different concentrations of volatile anesthetics on the threshold for cortical spreading depression in rats. Brain Res. 1992 May 22;581(1):153–155. doi: 10.1016/0006-8993(92)90355-d. [DOI] [PubMed] [Google Scholar]
  35. Warner D. S., Martin H., Ludwig P., McAllister A., Keana J. F., Weber E. In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists. J Cereb Blood Flow Metab. 1995 Mar;15(2):188–196. doi: 10.1038/jcbfm.1995.24. [DOI] [PubMed] [Google Scholar]
  36. Willetts J., Balster R. L., Leander J. D. The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci. 1990 Oct;11(10):423–428. doi: 10.1016/0165-6147(90)90150-7. [DOI] [PubMed] [Google Scholar]
  37. Wong E. H., Kemp J. A., Priestley T., Knight A. R., Woodruff G. N., Iversen L. L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7104–7108. doi: 10.1073/pnas.83.18.7104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Woodward R. M., Huettner J. E., Guastella J., Keana J. F., Weber E. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites. Mol Pharmacol. 1995 Mar;47(3):568–581. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES